Evercore's DiFiore on Amylyx Pharmaceuticals inc. (AMLX) ALS Relyvrio Launch: 'I feel very confident in launch and remain very constructive'
Tweet Send to a Friend
Evercore ISI analyst Umer Raffat reiterated an Outperform rating and {REMOVEPT} price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
